Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-२.६९%
१,०६८.२४
-२९.५७
-२.६९%
—१,०९७.८११,०८७.७६१,०८७.७६१,०६७.४२——
SIXC
Communications
SIXC
Communications
SIXC
-०.८९%
६०६.५९
-५.४४
-०.८९%
—६१२.०३६१२.०३६१२.०३६०६.१३——
SIXE
Energy
SIXE
Energy
SIXE
+२.१९%
१,२४७.२१
+२६.७८
+२.१९%
—१,२२०.४३१,२२१.९९१,२४७.६०१,२२१.९९——
SIXI
Industrials
SIXI
Industrials
SIXI
-१.८२%
१,७२७.५८
-३१.९४
-१.८२%
—१,७५९.५२१,७५४.३११,७५४.३११,७२३.६०——
SIXM
Financials
SIXM
Financials
SIXM
-०.३२%
६२९.५४
-२.००
-०.३२%
—६३१.५४६३१.२७६३३.९९६२८.६३——
SIXR
Staples
SIXR
Staples
SIXR
-०.४२%
८५३.६०
-३.५६
-०.४२%
—८५७.१६८५८.९१८६१.७१८५२.३३——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-१.५६%
२१२.०४
-३.३७
-१.५६%
—२१५.४१२१५.४१२१५.४१२११.८८——
SIXT
Technology
SIXT
Technology
SIXT
-१.७८%
३,५४९.७६
-६४.३९
-१.७८%
—३,६१४.१५३,५५६.२४३,५९८.३६३,५१६.८६——
SIXU
Utilities
SIXU
Utilities
SIXU
-२.४०%
८८६.४९
-२१.८१
-२.४०%
—९०८.३०९०६.५५९०६.५५८८५.८८——
SIXV
Health care
SIXV
Health care
SIXV
-१.०८%
१,४६४.३४
-१६.०६
-१.०८%
—१,४८०.४०१,४७९.५५१,४८४.४३१,४६२.५२——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-१.८४%
२,३५४.२५
-४४.१२
-१.८४%
—२,३९८.३७२,३७३.०९२,३७३.०९२,३५०.२७——
Q4 2026 earnings • released • Revenue beat +१०.९३%
See results
PRIVISCL:NSE
Privi Speciality Chemicals Ltd
₹ ३,०७८.००
+०.०९%
(+२.७०) 1D
मे १५, १५:३०:०४ GMT+५:३०  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for PRIVISCL...
Open
₹ ३,०८५.२०
High
₹ ३,१५०.००
Low
₹ ३,०५२.२०
Mkt. cap
१.२० खरब
Avg. vol.
१.२५ लाख
Volume
७३.९७ हजार
Dividend
०.३२%
Quarterly dividend
₹ २.५०
Ex dividend date
२०२६ जुलाई ३१
P/E ratio
४०.०३
52-wk high
₹ ३,५९०.९०
52-wk low
₹ २,०५०.००
EPS
₹ ७६.८९
No. of employees
६७२
News stories
From sources across the web
About Privi Speciality Chemicals Ltd
CEO-
Employees६७२
Founded१९८५
Headquarters-
SectorSpeciality chemicals
Websiteprivi.com
Last report
२०२६ मे १२
Fiscal Period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
७.२२ अरब / ६.५० अरब
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
५.५९ अरब
६.७९ अरब
६.०५ अरब
७.२६ अरब
Cost of goods sold
३.१४ अरब
३.८० अरब
३.४६ अरब
४.५१ अरब
Cost of revenue
३.१४ अरब
३.८० अरब
३.४६ अरब
४.५१ अरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२७.३९ करोड
२९.०२ करोड
३३.१९ करोड
२५.११ करोड
Operating expense
१.४९ अरब
१.५२ अरब
१.४३ अरब
१.२७ अरब
Total operating expenses
४.६३ अरब
५.३२ अरब
४.८९ अरब
५.७८ अरब
Operating income
९५.८६ करोड
१.४७ अरब
१.१६ अरब
१.४८ अरब
Other non operating income
८.९९ करोड
१०.७४ लाख
६.५१ करोड
-
EBT including unusual items
८१.१८ करोड
१.२५ अरब
१.०४ अरब
१.३० अरब
EBT excluding unusual items
८१.१८ करोड
१.२५ अरब
१.०४ अरब
१.३० अरब
Income tax expense
२३.६३ करोड
३४.८६ करोड
२८.९२ करोड
३५.५८ करोड
Effective tax rate
२९.११%
२७.८७%
२७.८७%
२७.४३%
Other operating expenses
८५.२२ करोड
८७.३१ करोड
७४.१७ करोड
६५.२६ करोड
Net income
६१.९३ करोड
९३.९१ करोड
७७.९९ करोड
९३.७० करोड
Net profit margin
११.०८%
१३.८४%
१२.९०%
१२.९९%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-२३.६६ करोड
-२१.४७ करोड
-१८.५७ करोड
-१८.२५ करोड
Net interest expenses
-२३.६६ करोड
-२१.४७ करोड
-१८.५७ करोड
-१८.२५ करोड
Depreciation and amortization charges
३६.२१ करोड
३५.६० करोड
३५.५१ करोड
३६.४८ करोड
EBITDA
१.२७ अरब
१.८१ अरब
१.४७ अरब
१.८२ अरब
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer